Summary
Vertex Pharmaceuticals Incorporated (VRTX) has entered into a significant Credit Agreement that establishes a $2.0 billion senior unsecured revolving facility, with an option to increase this capacity by an additional $500 million. This new facility, maturing on September 18, 2022, provides the company with substantial financial flexibility for general corporate purposes. The terms include variable interest rates based on either a base rate or Eurocurrency rate, plus an applicable margin that is tied to Vertex's consolidated leverage ratio, indicating a cost of borrowing that can fluctuate with the company's financial health. The Credit Agreement also incorporates important covenants for investors to note, including financial requirements to maintain a consolidated leverage ratio of 3.50 to 1.00 (or 4.00 to 1.00 post-material acquisition) and a consolidated interest coverage ratio of 2.50 to 1.00. These covenants demonstrate the company's commitment to financial discipline and underscore potential triggers for lender actions should these ratios be breached. The agreement is secured by guarantees from certain domestic subsidiaries, subject to exceptions, and includes standard provisions for representations, warranties, and events of default.
Key Highlights
- 1Entered into a $2.0 billion senior unsecured revolving credit facility, with an accordion feature to increase by an additional $500 million.
- 2The credit facility matures on September 18, 2022, providing a medium-term source of funding.
- 3Proceeds are designated for general corporate purposes, offering flexibility in capital allocation.
- 4Interest rates are variable, tied to either a base rate or Eurocurrency rate, plus an applicable margin based on the company's leverage ratio.
- 5Key financial covenants include maintaining a consolidated leverage ratio of 3.50:1.00 (extendable to 4.00:1.00 post-acquisition) and an interest coverage ratio of 2.50:1.00.
- 6Certain domestic subsidiaries will provide guarantees for the facility, subject to exceptions.
- 7The agreement includes standard representations, warranties, covenants, and events of default, allowing for remedies like loan acceleration upon default.